logo

Neurothrombectomy Devices Market Size (2024 - 2029)

The neurothrombectomy devices market is anticipated to experience growth over the forecast period, driven by factors such as the prevalence of acute ischemic strokes, particularly among the geriatric population and women over 55. The market's expansion was initially hindered by the COVID-19 pandemic, which disrupted production and demand, affected supply chains, and delayed clinical trials. However, as healthcare services normalize and the demand for these devices increases, the market size is expected to grow.

Home Market Analysis Healthcare Research Medical Devices Research Neurothrombectomy Devices Market Market Size

Market Size of Neurothrombectomy Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Neurothrombectomy Devices Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.50 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Neurothrombectomy Devices Market Key Players

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Neurothrombectomy Devices Market Analysis

The neurothrombectomy devices market is expected to register a CAGR of 6.5% over the forecast period, 2021-2026.

The outbreak of COVID-19 had an impact on the neurothrombectomy devices market, as hospital visits and the use of healthcare services significantly reduced due to the social distancing measures taken by governments worldwide. Moreover, the COVID-19 pandemic not only affected the global economy, but it also had a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals across the world. The outbreak of COVID-19 impacted the neurothrombectomy devices market by directly affecting the production and demand, creating a disruption in the supply chain and increasing the financial burden on companies. Due to this ongoing pandemic, scientists and biologists were unable to work from their labs, thus stalling the progress in the clinical trials that had started pre-COVID-19. Therefore, the new therapies have been delayed.

Acute ischemic strokes are the most prevalent type of stroke, and they are caused due to the reduction of blood supply to the brain, leading to the death of the brain cells. This problem is very commonly seen in the geriatric population. Ischemic strokes are more common in women than men, particularly in the age group of 55 years or above. Therefore, the above-mentioned factors are likely to positively boost the growth of the market during the forecast period.

Neurothrombectomy Devices Industry Segmentation

A neurothrombectomy device is used to destroy a blood clot in the brain (cerebral neuro vasculature) by mechanical, laser, or ultrasound technologies. It has become the most preferred treatment, as it has shown promising results in lowering the mortality rate in patients.

The neurothrombectomy devices market is segmented by product, end user, and geography. By product, it is segmented into clot retrievers, suction devices, and vascular snares. By end user, the market is segmented into hospitals, ambulatory surgical centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The report offers the value in USD million for the above-mentioned segments.

By Product
Clot Retrievers
Suction Devices
Vascular Snares
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Austalia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Neurothrombectomy Devices Market Size Summary

The neurothrombectomy devices market is poised for steady growth, driven by the increasing prevalence of acute ischemic strokes, particularly among the geriatric population. This market is characterized by the dominance of the clot retrievers segment, which is favored for its high efficacy and flexibility. The rise in ischemic stroke cases, attributed to aging and sedentary lifestyles, is expected to bolster market expansion. Additionally, government initiatives and advancements in novel drug developments for clot retrievers are anticipated to further propel market growth. The hospital segment remains a key player in the market due to the availability of advanced technological devices and a higher volume of patient visits compared to emergency clinics. The endovascular devices segment, including vascular snares, is also experiencing growth due to the increasing incidence of cardiac-related issues.

Regionally, North America leads the market, with the United States contributing significantly due to a high incidence of stroke-related cases and substantial investments in research and development. The region's growth is supported by increased awareness and technological advancements in stroke detection and therapy. Europe also plays a significant role in revenue generation, driven by a rising number of acute ischemic stroke patients and new product launches. The market is highly competitive, with major players like Abbott Laboratories, Johnson & Johnson, Medtronic, Stryker, and Vesalio intensifying competition through strategies such as mergers, acquisitions, and product innovations. Recent product launches and expansions by key players further highlight the dynamic nature of the market, with efforts to enhance market coverage and technological offerings across various regions.

Explore More

Neurothrombectomy Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increase in Geriatric Population

      2. 1.2.2 Increasing Prevalence of Ischemic Strokes

    3. 1.3 Market Restraints

      1. 1.3.1 Risks Associated with Neurothrombectomy Procedure

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Clot Retrievers

      2. 2.1.2 Suction Devices

      3. 2.1.3 Vascular Snares

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 Ambulatory Surgical Centers

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Spain

        5. 2.3.2.5 Italy

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Austalia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Neurothrombectomy Devices Market Size FAQs

The Neurothrombectomy Devices Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

Medtronic, Stryker, Siemens Healthineers, Acandis and INARI Medical are the major companies operating in the Neurothrombectomy Devices Market.

Neurothrombectomy Devices Report Snapshots

Neurothrombectomy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)